Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.

Suppr

超能文献

作者信息

Gallen Ian W, Carter Celia

出版信息

Diabetes Care. 2003 Dec;26(12):3352-3. doi: 10.2337/diacare.26.12.3352.

DOI:10.2337/diacare.26.12.3352

PMID:14633830

Abstract

摘要

相似文献

Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.

Diabetes Care. 2003 Dec;26(12):3352-3. doi: 10.2337/diacare.26.12.3352.

Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.

Diabetes Technol Ther. 2002;4(5):744-5.

Diabetes Care. 2004 Jan;27(1):272-3. doi: 10.2337/diacare.27.1.272-a.

Will the use of insulin analogs improve glycemic control during adolescence?

Pediatr Diabetes. 2003 Jun;4(2):61-3. doi: 10.1034/j.1399-5448.2003.00016.x.

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

Diabetes Care. 2004 Feb;27(2):632-3. doi: 10.2337/diacare.27.2.632.

Fasting and insulin glargine in individuals with type 1 diabetes.

Diabetes Care. 2004 May;27(5):1209-10. doi: 10.2337/diacare.27.5.1209.

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.

Diabetes Care. 2003 Apr;26(4):1321-2. doi: 10.2337/diacare.26.4.1321.

Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes.

Diabetes Technol Ther. 2003;5(5):801-6. doi: 10.1089/152091503322527003.

[Long acting insulin analogs: possibly more stable glucose regulation].

Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1674-8.

Insulin glargine clinical trials.

Clin Ther. 2004 Jul;26(7):1179-81; discussion 1182-3. doi: 10.1016/s0149-2918(04)90190-7.

引用本文的文献

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.

Patient. 2018 Aug;11(4):377-389. doi: 10.1007/s40271-017-0291-3.

In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.

J Diabetes Sci Technol. 2008 May;2(3):436-49. doi: 10.1177/193229680800200313.

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Cardiovasc Diabetol. 2009 Feb 16;8:9. doi: 10.1186/1475-2840-8-9.

Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.

Cardiovasc Diabetol. 2009 Jan 19;8:3. doi: 10.1186/1475-2840-8-3.

Insulin glargine in the treatment of type 1 and type 2 diabetes.

Vasc Health Risk Manag. 2006;2(1):59-67. doi: 10.2147/vhrm.2006.2.1.59.

From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?

Diabetologia. 2006 Nov;49(11):2793-4. doi: 10.1007/s00125-006-0454-6. Epub 2006 Sep 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验